Lipidic Systems for In Vivo siRNA Delivery
- 9 September 2009
- journal article
- review article
- Published by Springer Nature in The AAPS Journal
- Vol. 11 (4) , 639-652
Abstract
The ability of small-interfering RNA (siRNA) to silence specific target genes not only offers a tool to study gene function but also represents a novel appKeywords
This publication has 111 references indexed in Scilit:
- The promises and pitfalls of RNA-interference-based therapeuticsNature, 2009
- Durable Protection from Herpes Simplex Virus-2 Transmission Following Intravaginal Application of siRNAs Targeting Both a Viral and Host GeneCell Host & Microbe, 2009
- Nonviral Methods for siRNA DeliveryMolecular Pharmaceutics, 2008
- Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesiaEuropean Journal of Pharmacology, 2008
- An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumorJournal of Controlled Release, 2008
- Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverOncogene, 2008
- Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNAMolecular Therapy, 2008
- A combinatorial library of lipid-like materials for delivery of RNAi therapeuticsNature Biotechnology, 2008
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008
- Lung Delivery Studies Using siRNA Conjugated to TAT(48−60) and Penetratin Reveal Peptide Induced Reduction in Gene Expression and Induction of Innate ImmunityBioconjugate Chemistry, 2007